SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001023024-23-000005
Filing Date
2023-03-09
Accepted
2023-03-09 16:09:01
Documents
98
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K anip-20221231x10k.htm   iXBRL 10-K 3544829
2 EX-21 anip-20221231xex21.htm EX-21 6312
3 EX-23.1 anip-20221231xex23d1.htm EX-23.1 3277
4 EX-31.1 anip-20221231xex31d1.htm EX-31.1 13185
5 EX-31.2 anip-20221231xex31d2.htm EX-31.2 13212
6 EX-32.1 anip-20221231xex32d1.htm EX-32.1 8392
7 GRAPHIC anip-20221231x10k001.jpg GRAPHIC 75537
  Complete submission text file 0001023024-23-000005.txt   14684420

Data Files

Seq Description Document Type Size
8 EX-101.SCH anip-20221231.xsd EX-101.SCH 64980
9 EX-101.CAL anip-20221231_cal.xml EX-101.CAL 112113
10 EX-101.DEF anip-20221231_def.xml EX-101.DEF 376645
11 EX-101.LAB anip-20221231_lab.xml EX-101.LAB 633529
12 EX-101.PRE anip-20221231_pre.xml EX-101.PRE 619269
92 EXTRACTED XBRL INSTANCE DOCUMENT anip-20221231x10k_htm.xml XML 3002289
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 23719795
SIC: 2834 Pharmaceutical Preparations